Literature DB >> 20544340

The regulation of class IA PI 3-kinases by inter-subunit interactions.

Jonathan M Backer1.   

Abstract

Phosphoinositide 3-kinases (PI 3-kinases) are activated by growth factor and hormone receptors, and regulate cell growth, survival, motility, and responses to changes in nutritional conditions (Engelman et al. 2006). PI 3-kinases have been classified according to their subunit composition and their substrate specificity for phosphoinositides (Vanhaesebroeck et al. 2001). The class IA PI 3-kinase is a heterodimer consisting of one regulatory subunit (p85α, p85β, p55α, p50α, or p55γ) and one 110-kDa catalytic subunit (p110α, β or δ). The Class IB PI 3-kinase is also a dimer, composed of one regulatory subunit (p101 or p87) and one catalytic subunit (p110γ) (Wymann et al. 2003). Class I enzymes will utilize PI, PI[4]P, or PI[4,5]P2 as substrates in vitro, but are thought to primarily produce PI[3,4,5]P3 in cells.The crystal structure of the Class IB PI 3-kinase catalytic subunit p110γ was solved in 1999 (Walker et al. 1999), and crystal or NMR structures of the Class IA p110α catalytic subunit and all of the individual domains of the Class IA p85α regulatory subunit have been solved (Booker et al. 1992; Günther et al. 1996; Hoedemaeker et al. 1999; Huang et al. 2007; Koyama et al. 1993; Miled et al. 2007; Musacchio et al. 1996; Nolte et al. 1996; Siegal et al. 1998). However, a structure of an intact PI 3-kinase enzyme has remained elusive. In spite of this, studies over the past 10 years have lead to important insights into how the enzyme is regulated under physiological conditions. This chapter will specifically discuss the regulation of Class IA PI 3-kinase enzymatic activity, focusing on regulatory interactions between the p85 and p110 subunits and the modulation of these interactions by physiological activators and oncogenic mutations. The complex web of signaling downstream from Class IA PI 3-kinases will be discussed in other chapters in this volume.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20544340      PMCID: PMC3234103          DOI: 10.1007/82_2010_52

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  128 in total

1.  A novel 55-kDa regulatory subunit for phosphatidylinositol 3-kinase structurally similar to p55PIK Is generated by alternative splicing of the p85alpha gene.

Authors:  K Inukai; M Anai; E Van Breda; T Hosaka; H Katagiri; M Funaki; Y Fukushima; T Ogihara; Y Yazaki; Y Oka; T Asano
Journal:  J Biol Chem       Date:  1996-03-08       Impact factor: 5.157

2.  Crystal structure of the breakpoint cluster region-homology domain from phosphoinositide 3-kinase p85 alpha subunit.

Authors:  A Musacchio; L C Cantley; S C Harrison
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

3.  Interaction of Ras with phosphoinositide 3-kinase gamma.

Authors:  I Rubio; P Rodriguez-Viciana; J Downward; R Wetzker
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

4.  Rho family GTPases bind to phosphoinositide kinases.

Authors:  K F Tolias; L C Cantley; C L Carpenter
Journal:  J Biol Chem       Date:  1995-07-28       Impact factor: 5.157

5.  Crystal structure of the PI 3-kinase p85 amino-terminal SH2 domain and its phosphopeptide complexes.

Authors:  R T Nolte; M J Eck; J Schlessinger; S E Shoelson; S C Harrison
Journal:  Nat Struct Biol       Date:  1996-04

6.  Membrane localization of phosphatidylinositol 3-kinase is sufficient to activate multiple signal-transducing kinase pathways.

Authors:  A Klippel; C Reinhard; W M Kavanaugh; G Apell; M A Escobedo; L T Williams
Journal:  Mol Cell Biol       Date:  1996-08       Impact factor: 4.272

7.  Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation.

Authors:  P Rodriguez-Viciana; P H Warne; B Vanhaesebroeck; M D Waterfield; J Downward
Journal:  EMBO J       Date:  1996-05-15       Impact factor: 11.598

8.  NMR analysis of interactions of a phosphatidylinositol 3'-kinase SH2 domain with phosphotyrosine peptides reveals interdependence of major binding sites.

Authors:  U L Günther; Y Liu; D Sanford; W W Bachovchin; B Schaffhausen
Journal:  Biochemistry       Date:  1996-12-03       Impact factor: 3.162

9.  Rac GTPase interacts specifically with phosphatidylinositol 3-kinase.

Authors:  G M Bokoch; C J Vlahos; Y Wang; U G Knaus; A E Traynor-Kaplan
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

10.  Integrin-dependent translocation of phosphoinositide 3-kinase to the cytoskeleton of thrombin-activated platelets involves specific interactions of p85 alpha with actin filaments and focal adhesion kinase.

Authors:  C Guinebault; B Payrastre; C Racaud-Sultan; H Mazarguil; M Breton; G Mauco; M Plantavid; H Chap
Journal:  J Cell Biol       Date:  1995-05       Impact factor: 10.539

View more
  34 in total

Review 1.  Crossroads of PI3K and Rac pathways.

Authors:  Carlo C Campa; Elisa Ciraolo; Alessandra Ghigo; Giulia Germena; Emilio Hirsch
Journal:  Small GTPases       Date:  2015-05-05

Review 2.  The PI3K Pathway in Human Disease.

Authors:  David A Fruman; Honyin Chiu; Benjamin D Hopkins; Shubha Bagrodia; Lewis C Cantley; Robert T Abraham
Journal:  Cell       Date:  2017-08-10       Impact factor: 41.582

Review 3.  PI3Kβ-A Versatile Transducer for GPCR, RTK, and Small GTPase Signaling.

Authors:  Anne R Bresnick; Jonathan M Backer
Journal:  Endocrinology       Date:  2019-03-01       Impact factor: 4.736

Review 4.  PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances.

Authors:  Lomon So; David A Fruman
Journal:  Biochem J       Date:  2012-03-15       Impact factor: 3.857

Review 5.  Novel approaches to inhibitor design for the p110β phosphoinositide 3-kinase.

Authors:  Hashem A Dbouk; Jonathan M Backer
Journal:  Trends Pharmacol Sci       Date:  2013-02-12       Impact factor: 14.819

6.  Assembly and Molecular Architecture of the Phosphoinositide 3-Kinase p85α Homodimer.

Authors:  Jaclyn LoPiccolo; Seung Joong Kim; Yi Shi; Bin Wu; Haiyan Wu; Brian T Chait; Robert H Singer; Andrej Sali; Michael Brenowitz; Anne R Bresnick; Jonathan M Backer
Journal:  J Biol Chem       Date:  2015-10-16       Impact factor: 5.157

7.  PI3King the right partner: unique interactions and signaling by p110β.

Authors:  Hashem A Dbouk
Journal:  Postdoc J       Date:  2015-06

8.  GPCR Signaling Mediates Tumor Metastasis via PI3Kβ.

Authors:  Bassem D Khalil; Christine Hsueh; Yanyan Cao; Widian F Abi Saab; Yarong Wang; John S Condeelis; Anne R Bresnick; Jonathan M Backer
Journal:  Cancer Res       Date:  2016-03-24       Impact factor: 12.701

9.  Human oncoprotein MDM2 activates the Akt signaling pathway through an interaction with the repressor element-1 silencing transcription factor conferring a survival advantage to cancer cells.

Authors:  S Singh; M Ramamoorthy; C Vaughan; W A Yeudall; S Deb; S Palit Deb
Journal:  Cell Death Differ       Date:  2012-12-14       Impact factor: 15.828

10.  Hypoxia enhances glucocorticoid-induced apoptosis and cell cycle arrest via the PI3K/Akt signaling pathway in osteoblastic cells.

Authors:  Wanjing Zou; Shu Yang; Tie Zhang; Haimei Sun; Yuying Wang; Hong Xue; Deshan Zhou
Journal:  J Bone Miner Metab       Date:  2014-09-18       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.